| NCT03362476 |
Computer-based Intervention for Alcohol-using HIV/HCV+ Women |
https://ClinicalTrials.gov/show/NCT03362476 |
Active, not recruiting |
New York University |
2020-02-29 |
| NCT04370795 |
Matched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and Sirolimus |
https://ClinicalTrials.gov/show/NCT04370795 |
Enrolling by invitation |
National Institutes of Health Clinical Center (CC) |
2026-09-09 |
| NCT03408262 |
Clinical Trial of HIV Vaccine Combinations in Healthy Men and Women |
https://ClinicalTrials.gov/show/NCT03408262 |
Completed |
Imperial College London |
2020-02-10 |
| NCT03407105 |
A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV) |
https://ClinicalTrials.gov/show/NCT03407105 |
Completed |
Bristol-Myers Squibb |
2006-02-21 |
| NCT03383380 |
Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome |
https://ClinicalTrials.gov/show/NCT03383380 |
Recruiting |
Children’s Hospital of Fudan University |
2022-11-30 |
| NCT03369327 |
Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Virus |
https://ClinicalTrials.gov/show/NCT03369327 |
Completed |
Tehran University of Medical Sciences |
2018-09-01 |
| NCT03335176 |
Feasibility of Telerehabilitation in HIV-patients |
https://ClinicalTrials.gov/show/NCT03335176 |
Completed |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2015-04-01 |
| NCT03333486 |
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer |
https://ClinicalTrials.gov/show/NCT03333486 |
Recruiting |
Roswell Park Cancer Institute |
2022-09-06 |
| NCT03315078 |
Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency |
https://ClinicalTrials.gov/show/NCT03315078 |
Recruiting |
National Institute of Allergy and Infectious Diseases (NIAID) |
2022-12-31 |
| NCT03314064 |
Phase 4 Study of Dolutegravir (DTG) in Russian Federation |
https://ClinicalTrials.gov/show/NCT03314064 |
Completed |
ViiV Healthcare |
2018-10-01 |
| NCT03307915 |
A Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral Treatment |
https://ClinicalTrials.gov/show/NCT03307915 |
Active, not recruiting |
Janssen Vaccines & Prevention B.V. |
2020-10-20 |
| NCT03301168 |
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT03301168 |
Active, not recruiting |
Bellicum Pharmaceuticals |
2020-02-29 |
| NCT03277313 |
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects |
https://ClinicalTrials.gov/show/NCT03277313 |
Active, not recruiting |
Shire |
2023-05-31 |
| NCT03266653 |
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection |
https://ClinicalTrials.gov/show/NCT03266653 |
Recruiting |
New York Medical College |
2020-12-31 |
| NCT03266640 |
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) |
https://ClinicalTrials.gov/show/NCT03266640 |
Recruiting |
New York Medical College |
2020-12-31 |
| NCT03266627 |
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection |
https://ClinicalTrials.gov/show/NCT03266627 |
Recruiting |
New York Medical College |
2020-12-31 |
| NCT03250910 |
Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients |
https://ClinicalTrials.gov/show/NCT03250910 |
Completed |
National Taiwan University Hospital |
2017-07-15 |
| NCT03238079 |
Study of PlasmaCap IG in Adults and Children With PIDD |
https://ClinicalTrials.gov/show/NCT03238079 |
Active, not recruiting |
Therapure Biopharma Inc |
2020-08-25 |
| NCT03235349 |
Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection |
https://ClinicalTrials.gov/show/NCT03235349 |
Completed |
AbbVie |
2018-11-15 |
| NCT03222583 |
A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection |
https://ClinicalTrials.gov/show/NCT03222583 |
Completed |
AbbVie |
2018-10-18 |
| NCT03211689 |
The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease |
https://ClinicalTrials.gov/show/NCT03211689 |
Completed |
Stockton University |
2017-12-31 |
| NCT03211065 |
Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous Ig |
https://ClinicalTrials.gov/show/NCT03211065 |
Active, not recruiting |
Rochester General Hospital |
2019-12-31 |
| NCT03182738 |
Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms |
https://ClinicalTrials.gov/show/NCT03182738 |
Completed |
Columbia University |
2019-04-03 |
| NCT03166449 |
Effects of Immunonutrition on Biomarkers in Traumatic Brain Injury |
https://ClinicalTrials.gov/show/NCT03166449 |
Completed |
University of Malaya |
2015-07-31 |
| NCT03149848 |
Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT03149848 |
Completed |
ViiV Healthcare |
2017-09-06 |
| NCT03116347 |
Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects |
https://ClinicalTrials.gov/show/NCT03116347 |
Active, not recruiting |
Shire |
2023-11-30 |
| NCT03098654 |
Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care In Kisarawe, Tanzania |
https://ClinicalTrials.gov/show/NCT03098654 |
Active, not recruiting |
Medical University of South Carolina |
2021-06-30 |
| NCT03052491 |
Effects of a 10 Component Dietary Supplement on Health and the Quality of Life |
https://ClinicalTrials.gov/show/NCT03052491 |
Completed |
Centagen, Inc. |
2016-08-24 |
| NCT03051425 |
Immune Benefits of Consumption of Dairy Yogurt in Elderly |
https://ClinicalTrials.gov/show/NCT03051425 |
Completed |
Yonsei University |
2017-01-10 |
| NCT03045861 |
Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults |
https://ClinicalTrials.gov/show/NCT03045861 |
Completed |
GlaxoSmithKline |
2018-04-23 |
| NCT03033745 |
Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID) |
https://ClinicalTrials.gov/show/NCT03033745 |
Completed |
CSL Behring |
2018-12-14 |
| NCT03016806 |
Umbilical Cord Blood Transplantation From Unrelated Donors |
https://ClinicalTrials.gov/show/NCT03016806 |
Recruiting |
University of Rochester |
2025-06-30 |
| NCT02999984 |
Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID |
https://ClinicalTrials.gov/show/NCT02999984 |
Completed |
Orchard Therapeutics |
2018-10-11 |
| NCT02974998 |
Cape Town Young Women’s Health CoOp |
https://ClinicalTrials.gov/show/NCT02974998 |
Completed |
RTI International |
2019-11-26 |
| NCT02965014 |
NC Young Women’s CoOp |
https://ClinicalTrials.gov/show/NCT02965014 |
Active, not recruiting |
RTI International |
2020-07-31 |
| NCT02954640 |
Evaluation of the Efficacy of the Sequencing Method by Gene-panel |
https://ClinicalTrials.gov/show/NCT02954640 |
Completed |
Imagine Institute |
2017-09-08 |
| NCT02929069 |
A Unified Intervention for Young Gay and Bisexual Men’s Minority Stress, Mental Health, and HIV Risk |
https://ClinicalTrials.gov/show/NCT02929069 |
Active, not recruiting |
Yale University |
2020-08-31 |
| NCT02919306 |
Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults |
https://ClinicalTrials.gov/show/NCT02919306 |
Completed |
Janssen Vaccines & Prevention B.V. |
2018-09-30 |
| NCT02895204 |
Effect of Fermented Maillard Reacted Whey Protein on Immune Function |
https://ClinicalTrials.gov/show/NCT02895204 |
Completed |
Yonsei University |
2016-06-30 |
| NCT02881762 |
Maraviroc Efficacy for Hepatitis C |
https://ClinicalTrials.gov/show/NCT02881762 |
Completed |
University of Maryland, Baltimore |
2019-03-27 |
| NCT02881437 |
IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQvia |
https://ClinicalTrials.gov/show/NCT02881437 |
Completed |
University Hospital, Lille |
2018-03-16 |
| NCT02831673 |
An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1) |
https://ClinicalTrials.gov/show/NCT02831673 |
Active, not recruiting |
ViiV Healthcare |
2018-03-29 |
| NCT02818283 |
Soy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary Intervention |
https://ClinicalTrials.gov/show/NCT02818283 |
Recruiting |
Ohio State University |
2020-12-31 |
| NCT02817451 |
DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants |
https://ClinicalTrials.gov/show/NCT02817451 |
Completed |
Sanofi |
2019-02-22 |
| NCT02810444 |
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID |
https://ClinicalTrials.gov/show/NCT02810444 |
Completed |
Biotest |
2020-04-01 |
| NCT02806986 |
Efficacy, Pharmacokinetics, Safety, and Tolerability of IGSC 20% in Subjects With Primary Immunodeficiency |
https://ClinicalTrials.gov/show/NCT02806986 |
Completed |
Grifols Therapeutics LLC |
2019-05-15 |
| NCT02771600 |
Pilot Study of a New Device (Buzzy®) for Procedural Pain Relief During Needle-Related Procedures in Paediatric Patients |
https://ClinicalTrials.gov/show/NCT02771600 |
Completed |
St. Justine’s Hospital |
2018-09-15 |
| NCT02738138 |
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2) |
https://ClinicalTrials.gov/show/NCT02738138 |
Completed |
AbbVie |
2017-03-15 |
| NCT02711228 |
Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules |
https://ClinicalTrials.gov/show/NCT02711228 |
Completed |
CSL Behring |
2018-01-30 |
| NCT02670772 |
Dose Optimisation of Stavudine for the Treatment of HIV Infection |
https://ClinicalTrials.gov/show/NCT02670772 |
Completed |
University of Witwatersrand, South Africa |
2014-12-31 |
| NCT02660281 |
URMC Related Haplo-identical Donor BMT |
https://ClinicalTrials.gov/show/NCT02660281 |
Recruiting |
University of Rochester |
2025-10-31 |
| NCT02659761 |
Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject Drugs |
https://ClinicalTrials.gov/show/NCT02659761 |
Recruiting |
University College Dublin |
2020-12-31 |
| NCT02651376 |
Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients |
https://ClinicalTrials.gov/show/NCT02651376 |
Completed |
Beijing 302 Hospital |
2017-04-30 |
| NCT02639754 |
Community Intervention for HIV Testing & Care Linkage Among Young MSM in Bulgaria |
https://ClinicalTrials.gov/show/NCT02639754 |
Enrolling by invitation |
Medical College of Wisconsin |
2020-12-31 |
| NCT02630082 |
Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru |
https://ClinicalTrials.gov/show/NCT02630082 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-03-31 |
| NCT02627300 |
Study of Octanorm Subcutaneous IG in Patients With Primary Immunodeficiency Diseases Who Have Completed the SCGAM-01 Trial |
https://ClinicalTrials.gov/show/NCT02627300 |
Completed |
Octapharma |
2019-09-05 |
| NCT02604810 |
Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency |
https://ClinicalTrials.gov/show/NCT02604810 |
Completed |
Grifols Therapeutics LLC |
2017-09-30 |
| NCT02600325 |
Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV |
https://ClinicalTrials.gov/show/NCT02600325 |
Completed |
Erasmus Medical Center |
2018-04-01 |
| NCT02990819 |
Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies |
https://ClinicalTrials.gov/show/NCT02990819 |
Recruiting |
Children’s Hospital of Philadelphia |
2023-12-31 |
| NCT02494986 |
A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric Studies |
https://ClinicalTrials.gov/show/NCT02494986 |
Recruiting |
Janssen Sciences Ireland UC |
2030-12-31 |
| NCT02572401 |
Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American Men |
https://ClinicalTrials.gov/show/NCT02572401 |
Completed |
University of Pennsylvania |
2013-06-30 |
| NCT02571595 |
A Sleep Program to Improve Sleep Quality in People With HIV |
https://ClinicalTrials.gov/show/NCT02571595 |
Active, not recruiting |
McGill University |
2020-01-31 |
| NCT02571504 |
Cognitive Training for the Remediation of Functional Brain Health in HIV |
https://ClinicalTrials.gov/show/NCT02571504 |
Completed |
McGill University |
2017-05-31 |
| NCT02561286 |
Being Responsible for Ourselves HIV Risk Reduction for Black MSM |
https://ClinicalTrials.gov/show/NCT02561286 |
Completed |
University of Pennsylvania |
2012-05-31 |
| NCT02741128 |
Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults |
https://ClinicalTrials.gov/show/NCT02741128 |
Active, not recruiting |
Sanofi |
2022-06-30 |
| NCT02016924 |
Study Evaluating Pharmacokinetics (PK), Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in HIV-1 Infected, Virologically Suppressed Pediatric Participants |
https://ClinicalTrials.gov/show/NCT02016924 |
Active, not recruiting |
Gilead Sciences |
2021-10-31 |
| NCT02538952 |
Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected Persons |
https://ClinicalTrials.gov/show/NCT02538952 |
Completed |
Centers for Disease Control and Prevention |
2017-07-01 |
| NCT02537236 |
Omega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet. |
https://ClinicalTrials.gov/show/NCT02537236 |
Completed |
Instituto Mexicano del Seguro Social |
2009-05-31 |
| NCT02508584 |
Personalized Immunotherapeutic for Antibiotic-resistant Infection |
https://ClinicalTrials.gov/show/NCT02508584 |
Completed |
Brigham and Women’s Hospital |
2019-06-12 |
| NCT02503293 |
A Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push |
https://ClinicalTrials.gov/show/NCT02503293 |
Completed |
Octapharma |
2017-12-11 |
| NCT02479698 |
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus |
https://ClinicalTrials.gov/show/NCT02479698 |
Recruiting |
M.D. Anderson Cancer Center |
2020-07-31 |
| NCT02435173 |
Study of Efficacy of CDZ173 in Patients With APDS/PASLI |
https://ClinicalTrials.gov/show/NCT02435173 |
Recruiting |
Novartis |
2021-06-08 |
| NCT02431247 |
A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects |
https://ClinicalTrials.gov/show/NCT02431247 |
Active, not recruiting |
Janssen Sciences Ireland UC |
2017-03-02 |
| NCT02403674 |
Comparison of MK-1439A and ATRIPLAâ„¢ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021) |
https://ClinicalTrials.gov/show/NCT02403674 |
Active, not recruiting |
Merck Sharp & Dohme Corp. |
2017-03-20 |
| NCT02383797 |
Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against Chickenpox |
https://ClinicalTrials.gov/show/NCT02383797 |
Active, not recruiting |
Helsinki University Central Hospital |
2019-10-31 |
| NCT02358226 |
HIV & Drug Abuse Prevention for South African Men |
https://ClinicalTrials.gov/show/NCT02358226 |
Completed |
University of California, Los Angeles |
2020-01-31 |
| NCT02348177 |
Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB |
https://ClinicalTrials.gov/show/NCT02348177 |
Completed |
Drugs for Neglected Diseases |
2016-12-31 |
| NCT02345707 |
Relative Bioavailability Study of Phase III Tablet Formulation of Cabotegravir |
https://ClinicalTrials.gov/show/NCT02345707 |
Completed |
ViiV Healthcare |
2015-06-30 |
| NCT02337595 |
Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT02337595 |
Completed |
Federal Research Institute of Pediatric Hematology, Oncology and Immunology |
2015-03-31 |
| NCT02337322 |
Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted Darunavir |
https://ClinicalTrials.gov/show/NCT02337322 |
Active, not recruiting |
Hospital Clinic of Barcelona |
2019-12-31 |
| NCT02334943 |
Immune Activation in HIV-1 Infected Patients Under AntiRetroviral Treatment |
https://ClinicalTrials.gov/show/NCT02334943 |
Completed |
University Hospital, Montpellier |
2015-03-31 |
| NCT02282293 |
Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2) |
https://ClinicalTrials.gov/show/NCT02282293 |
Completed |
University of California, San Francisco |
2016-05-26 |
| NCT02269917 |
Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants |
https://ClinicalTrials.gov/show/NCT02269917 |
Active, not recruiting |
Janssen R&D Ireland |
2017-02-17 |
| NCT02269163 |
Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10% |
https://ClinicalTrials.gov/show/NCT02269163 |
Completed |
Prometic Biotherapeutics, Inc. |
2019-01-11 |
| NCT02266992 |
Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study |
https://ClinicalTrials.gov/show/NCT02266992 |
Completed |
Sheffield Teaching Hospitals NHS Foundation Trust |
2015-06-30 |
| NCT02244450 |
Generalized Neonatal Screening of Severe Combined Immunodeficiencies |
https://ClinicalTrials.gov/show/NCT02244450 |
Completed |
Nantes University Hospital |
2018-04-28 |
| NCT02234492 |
The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients |
https://ClinicalTrials.gov/show/NCT02234492 |
Completed |
Ottawa Heart Institute Research Corporation |
2018-10-31 |
| NCT02231710 |
Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases |
https://ClinicalTrials.gov/show/NCT02231710 |
Active, not recruiting |
Bellicum Pharmaceuticals |
2015-07-16 |
| NCT02196831 |
Tesamorelin Effects on Liver Fat and Histology in HIV |
https://ClinicalTrials.gov/show/NCT02196831 |
Completed |
Massachusetts General Hospital |
2019-01-16 |
| NCT02178592 |
Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection |
https://ClinicalTrials.gov/show/NCT02178592 |
Completed |
ViiV Healthcare |
2017-11-02 |
| NCT02149888 |
PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5 |
https://ClinicalTrials.gov/show/NCT02149888 |
Completed |
St. Michael’s Hospital, Toronto |
2016-06-30 |
| NCT02128828 |
Effect of Cenicriviroc on HIV Neurocognitive Impairment |
https://ClinicalTrials.gov/show/NCT02128828 |
Completed |
University of Hawaii |
2016-06-30 |
| NCT02120352 |
A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects |
https://ClinicalTrials.gov/show/NCT02120352 |
Active, not recruiting |
ViiV Healthcare |
2015-08-13 |
| NCT02119390 |
Medication Adherence in Human Immunodeficiency Virus (HIV) |
https://ClinicalTrials.gov/show/NCT02119390 |
Completed |
St. Jude Children’s Research Hospital |
2016-07-31 |
| NCT02116179 |
DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients |
https://ClinicalTrials.gov/show/NCT02116179 |
Completed |
University of Delaware |
2016-05-31 |
| NCT02103439 |
An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients |
https://ClinicalTrials.gov/show/NCT02103439 |
Completed |
Biocad |
2015-08-26 |
| NCT02076178 |
Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR) |
https://ClinicalTrials.gov/show/NCT02076178 |
Completed |
ViiV Healthcare |
2015-05-15 |
| NCT01313507 |
High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam) |
https://ClinicalTrials.gov/show/NCT01313507 |
Completed |
Octapharma |
2012-09-30 |
| NCT01306019 |
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID) |
https://ClinicalTrials.gov/show/NCT01306019 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2024-12-31 |
| NCT01289951 |
Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis |
https://ClinicalTrials.gov/show/NCT01289951 |
Completed |
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal |
2011-06-30 |
| NCT01289847 |
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency |
https://ClinicalTrials.gov/show/NCT01289847 |
Completed |
Bio Products Laboratory |
2014-04-30 |
| NCT03164967 |
Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16 |
https://ClinicalTrials.gov/show/NCT03164967 |
Recruiting |
ADMA Biologics, Inc. |
2021-03-31 |
| NCT03352219 |
Reality Check: An HIV Risk Reduction Serial Drama |
https://ClinicalTrials.gov/show/NCT03352219 |
Completed |
University of Pennsylvania |
2017-03-31 |
| NCT01998633 |
Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) |
https://ClinicalTrials.gov/show/NCT01998633 |
Completed |
Medical College of Wisconsin |
2016-09-23 |
| NCT01985373 |
Pharmacokinetics and Safety of IVIG Nanogam 100 mg/ml |
https://ClinicalTrials.gov/show/NCT01985373 |
Completed |
Sanquin Plasma Products BV |
2015-03-31 |
| NCT01968551 |
Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults |
https://ClinicalTrials.gov/show/NCT01968551 |
Completed |
Gilead Sciences |
2015-07-21 |
| NCT01967940 |
Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults |
https://ClinicalTrials.gov/show/NCT01967940 |
Completed |
Gilead Sciences |
2015-05-21 |
| NCT01966367 |
CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT01966367 |
Active, not recruiting |
Columbia University |
2022-01-31 |
| NCT01963143 |
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases |
https://ClinicalTrials.gov/show/NCT01963143 |
Completed |
Bio Products Laboratory |
2016-01-31 |
| NCT01946906 |
The Rifaximin Study in CVID |
https://ClinicalTrials.gov/show/NCT01946906 |
Completed |
Oslo University Hospital |
2014-12-31 |
| NCT01939197 |
A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection |
https://ClinicalTrials.gov/show/NCT01939197 |
Completed |
AbbVie |
2016-07-21 |
| NCT01916759 |
Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda |
https://ClinicalTrials.gov/show/NCT01916759 |
Completed |
Emory University |
2013-12-31 |
| NCT01910402 |
A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA) |
https://ClinicalTrials.gov/show/NCT01910402 |
Active, not recruiting |
ViiV Healthcare |
2015-09-22 |
| NCT01904994 |
Link4Health: A Combination Strategy for Linkage and Retention, Swaziland |
https://ClinicalTrials.gov/show/NCT01904994 |
Active, not recruiting |
Columbia University |
2016-05-31 |
| NCT01888484 |
Study of Octanorm Subcutaneous IG in Patients With PID |
https://ClinicalTrials.gov/show/NCT01888484 |
Active, not recruiting |
Octapharma |
2020-07-31 |
| NCT01884311 |
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases |
https://ClinicalTrials.gov/show/NCT01884311 |
Completed |
Bio Products Laboratory |
2017-05-25 |
| NCT01866267 |
Switching Undetectables to Selzentry |
https://ClinicalTrials.gov/show/NCT01866267 |
Completed |
St. Hope Foundation |
2013-12-31 |
| NCT01861106 |
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations |
https://ClinicalTrials.gov/show/NCT01861106 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-12-31 |
| NCT01854775 |
Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children |
https://ClinicalTrials.gov/show/NCT01854775 |
Active, not recruiting |
Gilead Sciences |
2020-11-30 |
| NCT01852370 |
Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases |
https://ClinicalTrials.gov/show/NCT01852370 |
Enrolling by invitation |
University of Pittsburgh |
2023-11-30 |
| NCT01848483 |
Living Well Project for Persons With AIDS |
https://ClinicalTrials.gov/show/NCT01848483 |
Completed |
Emory University |
2017-06-30 |
| NCT01840722 |
Brief Intervention for Rural Women at High Risk for HIV/HCV |
https://ClinicalTrials.gov/show/NCT01840722 |
Completed |
University of Kentucky |
2019-05-31 |
| NCT01821781 |
Immune Disorder HSCT Protocol |
https://ClinicalTrials.gov/show/NCT01821781 |
Recruiting |
Washington University School of Medicine |
2022-03-31 |
| NCT01814800 |
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD) |
https://ClinicalTrials.gov/show/NCT01814800 |
Completed |
ADMA Biologics, Inc. |
2014-12-31 |
| NCT01812980 |
Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women |
https://ClinicalTrials.gov/show/NCT01812980 |
Completed |
University of Witwatersrand, South Africa |
2013-07-31 |
| NCT01783678 |
A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults |
https://ClinicalTrials.gov/show/NCT01783678 |
Completed |
Gilead Sciences |
2014-04-30 |
| NCT01766076 |
Atorvastatin for HAART Suboptimal Responders |
https://ClinicalTrials.gov/show/NCT01766076 |
Completed |
Makerere University |
2014-02-28 |
| NCT01727895 |
Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans |
https://ClinicalTrials.gov/show/NCT01727895 |
Completed |
Radboud University |
2013-07-31 |
| NCT01721109 |
Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents |
https://ClinicalTrials.gov/show/NCT01721109 |
Completed |
Gilead Sciences |
2015-10-22 |
| NCT01709084 |
A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment |
https://ClinicalTrials.gov/show/NCT01709084 |
Active, not recruiting |
Janssen-Cilag International NV |
2015-10-22 |
| NCT01705574 |
Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women |
https://ClinicalTrials.gov/show/NCT01705574 |
Completed |
Gilead Sciences |
2015-02-09 |
| NCT01683461 |
Efficacy of HIV Post-Test Support for ANC in South Africa |
https://ClinicalTrials.gov/show/NCT01683461 |
Completed |
University of North Carolina, Chapel Hill |
2011-12-31 |
| NCT01671501 |
Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients |
https://ClinicalTrials.gov/show/NCT01671501 |
Completed |
University of California, San Francisco |
2016-08-31 |
| NCT01667731 |
Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults |
https://ClinicalTrials.gov/show/NCT01667731 |
Completed |
Gilead Sciences |
2013-11-30 |
| NCT01652092 |
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies |
https://ClinicalTrials.gov/show/NCT01652092 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2021-12-31 |
| NCT01647191 |
Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China |
https://ClinicalTrials.gov/show/NCT01647191 |
Completed |
Shanghai Mental Health Center |
2015-05-01 |
| NCT01641809 |
Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine |
https://ClinicalTrials.gov/show/NCT01641809 |
Completed |
ViiV Healthcare |
2013-10-10 |
| NCT01590017 |
Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer |
https://ClinicalTrials.gov/show/NCT01590017 |
Completed |
AIDS Malignancy Consortium |
2017-04-20 |
| NCT01570595 |
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV |
https://ClinicalTrials.gov/show/NCT01570595 |
Completed |
Georgetown University |
2013-07-31 |
| NCT01565850 |
D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults |
https://ClinicalTrials.gov/show/NCT01565850 |
Completed |
Gilead Sciences |
2013-01-31 |
| NCT01533259 |
Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients |
https://ClinicalTrials.gov/show/NCT01533259 |
Completed |
Gilead Sciences |
2012-11-30 |
| NCT01516970 |
Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r) |
https://ClinicalTrials.gov/show/NCT01516970 |
Completed |
Janssen-Cilag G.m.b.H |
2013-08-01 |
| NCT01512888 |
Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants |
https://ClinicalTrials.gov/show/NCT01512888 |
Recruiting |
St. Jude Children’s Research Hospital |
2025-08-31 |
| NCT01502618 |
Intervention for HIV-Positive Black Young Men Who Have Sex With Men (YMSM) |
https://ClinicalTrials.gov/show/NCT01502618 |
Completed |
University of North Carolina, Chapel Hill |
2011-01-31 |
| NCT01497899 |
Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults |
https://ClinicalTrials.gov/show/NCT01497899 |
Completed |
Gilead Sciences |
2012-10-17 |
| NCT01495702 |
Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients |
https://ClinicalTrials.gov/show/NCT01495702 |
Completed |
Gilead Sciences |
2013-11-30 |
| NCT01490359 |
Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men |
https://ClinicalTrials.gov/show/NCT01490359 |
Completed |
University of Pennsylvania |
2009-12-31 |
| NCT01485796 |
Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD |
https://ClinicalTrials.gov/show/NCT01485796 |
Completed |
Shire |
2013-01-01 |
| NCT01479868 |
A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1 |
https://ClinicalTrials.gov/show/NCT01479868 |
Completed |
Janssen R&D Ireland |
2013-08-31 |
| NCT01475838 |
Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients |
https://ClinicalTrials.gov/show/NCT01475838 |
Completed |
Gilead Sciences |
2013-11-30 |
| NCT01465958 |
Pharmacokinetics, Safety, and Tolerability of Subcutaneous GAMUNEX-C in Pediatric Subjects With Primary Immunodeficiency |
https://ClinicalTrials.gov/show/NCT01465958 |
Completed |
Grifols Therapeutics LLC |
2013-10-31 |
| NCT01461018 |
Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study) |
https://ClinicalTrials.gov/show/NCT01461018 |
Completed |
CSL Behring |
2014-07-31 |
| NCT01458171 |
Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) |
https://ClinicalTrials.gov/show/NCT01458171 |
Completed |
CSL Behring |
2012-02-29 |
| NCT01455740 |
A Commitment Device for Medication Adherence Among HIV Patients |
https://ClinicalTrials.gov/show/NCT01455740 |
Completed |
National Bureau of Economic Research, Inc. |
2013-06-30 |
| NCT01449006 |
A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac) |
https://ClinicalTrials.gov/show/NCT01449006 |
Completed |
St Vincent’s Hospital, Sydney |
2014-09-30 |
| NCT01448707 |
A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment |
https://ClinicalTrials.gov/show/NCT01448707 |
Completed |
Janssen-Cilag International NV |
2014-06-11 |
| NCT01440569 |
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults |
https://ClinicalTrials.gov/show/NCT01440569 |
Completed |
Gilead Sciences |
2012-08-31 |
| NCT01433185 |
Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV |
https://ClinicalTrials.gov/show/NCT01433185 |
Completed |
University of Washington |
2013-07-31 |
| NCT01425073 |
Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya |
https://ClinicalTrials.gov/show/NCT01425073 |
Completed |
University of Washington |
2013-10-31 |
| NCT01422330 |
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients |
https://ClinicalTrials.gov/show/NCT01422330 |
Completed |
Janssen R&D Ireland |
2013-11-30 |
| NCT01420627 |
EZN-2279 in Patients With ADA-SCID |
https://ClinicalTrials.gov/show/NCT01420627 |
Completed |
Leadiant Biosciences, Inc. |
2018-04-10 |
| NCT01412385 |
Immune Globulin Subcutaenous (Human), 20% |
https://ClinicalTrials.gov/show/NCT01412385 |
Completed |
Shire |
2014-05-13 |
| NCT01406470 |
Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SNâ„¢ in Subjects With Primary Immunodeficiency |
https://ClinicalTrials.gov/show/NCT01406470 |
Completed |
Green Cross Corporation |
2013-07-31 |
| NCT01403792 |
A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects |
https://ClinicalTrials.gov/show/NCT01403792 |
Completed |
University of Surrey |
2011-11-30 |
| NCT01401335 |
HIV Prevention and Care of Psychological Trauma in Vulnerable Rwandan Youth |
https://ClinicalTrials.gov/show/NCT01401335 |
Completed |
Stanford University |
2010-12-31 |
| NCT01391013 |
A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients |
https://ClinicalTrials.gov/show/NCT01391013 |
Completed |
Janssen-Cilag S.p.A. |
2011-04-30 |
| NCT01384734 |
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections |
https://ClinicalTrials.gov/show/NCT01384734 |
Completed |
ViiV Healthcare |
2013-02-18 |
| NCT01369056 |
HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence |
https://ClinicalTrials.gov/show/NCT01369056 |
Completed |
University of Tartu |
2011-12-31 |
| NCT01363011 |
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment |
https://ClinicalTrials.gov/show/NCT01363011 |
Completed |
Gilead Sciences |
2013-01-31 |
| NCT04286815 |
Gene Therapy for X Linked Severe Combined Immunodeficiency |
https://ClinicalTrials.gov/show/NCT04286815 |
Recruiting |
Children’s Hospital of Chongqing Medical University |
2023-05-01 |
| NCT04232085 |
Reduced Intensity BMT for Immune Dysregulatory and Bone Marrow Failure Syndromes Using Post-Transplant Cyclophosphamide |
https://ClinicalTrials.gov/show/NCT04232085 |
Recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2024-12-31 |
| NCT04223804 |
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With HIV-1 |
https://ClinicalTrials.gov/show/NCT04223804 |
Recruiting |
AbbVie |
2021-11-20 |
| NCT04192487 |
Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea |
https://ClinicalTrials.gov/show/NCT04192487 |
Recruiting |
Napo Pharmaceuticals, Inc. |
2020-04-30 |
| NCT04140539 |
A Clinical Study to Enable Process Validation of Commercial Grade OTL-101 |
https://ClinicalTrials.gov/show/NCT04140539 |
Recruiting |
Orchard Therapeutics |
2020-08-30 |
| NCT04135937 |
Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH) |
https://ClinicalTrials.gov/show/NCT04135937 |
Recruiting |
VA Office of Research and Development |
2021-07-01 |
| NCT04122404 |
POC Strategies to Improve TB Care in Advanced HIV Disease |
https://ClinicalTrials.gov/show/NCT04122404 |
Recruiting |
University of Southern Denmark |
2021-08-15 |
| NCT04069546 |
The Efficacy of Remote Ischemic Conditioning on Stroke-induced Immunodeficiency |
https://ClinicalTrials.gov/show/NCT04069546 |
Recruiting |
Capital Medical University |
2020-02-01 |
| NCT04003701 |
Using a Humanoid Robot to Distract Children With Cancer or Chronic Immune Deficiency Undergoing Painful Procedures |
https://ClinicalTrials.gov/show/NCT04003701 |
Recruiting |
Vrije Universiteit Brussel |
2020-12-31 |
| NCT03996538 |
Vaccination Efficacy With Metformin in Older Adults |
https://ClinicalTrials.gov/show/NCT03996538 |
Active, not recruiting |
UConn Health |
2021-03-31 |
| NCT03988426 |
Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases |
https://ClinicalTrials.gov/show/NCT03988426 |
Completed |
Octapharma |
2018-01-26 |
| NCT03968211 |
Undetectable IgE as a Sentinel Biomarker for Humoral Immunodeficiency |
https://ClinicalTrials.gov/show/NCT03968211 |
Recruiting |
University of Virginia |
2021-06-30 |
| NCT03939533 |
Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases |
https://ClinicalTrials.gov/show/NCT03939533 |
Recruiting |
Octapharma |
2021-03-31 |
| NCT03907241 |
Study to Monitor the Safety, Tolerability and Efficacy of Subcutaneous Human Immunoglobulin (Octanorm) in Patients With Primary Immunodeficiency Diseases, Including (But Not Limited to) Those Who Have Completed the SCGAM-01 Trial |
https://ClinicalTrials.gov/show/NCT03907241 |
Completed |
Octapharma |
2019-08-16 |
| NCT03899480 |
Adoptive Transfer of Haploidentical NK Cells and N-803 |
https://ClinicalTrials.gov/show/NCT03899480 |
Recruiting |
University of Minnesota |
2020-09-01 |
| NCT03896932 |
Minipooled-IVIG in Primary Immunodeficiency Disease |
https://ClinicalTrials.gov/show/NCT03896932 |
Completed |
Assiut University |
2020-05-01 |
| NCT03836690 |
Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT03836690 |
Recruiting |
University College, London |
2022-07-01 |
| NCT03835312 |
Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM |
https://ClinicalTrials.gov/show/NCT03835312 |
Recruiting |
Children’s Hospital of Fudan University |
2024-12-31 |
| NCT03827278 |
Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole Therapy |
https://ClinicalTrials.gov/show/NCT03827278 |
Recruiting |
Guangxi Medical University |
2021-12-30 |
| NCT01218438 |
Phase 2/3 Study of IGSC, 20% in PIDD |
https://ClinicalTrials.gov/show/NCT01218438 |
Completed |
Shire |
2015-03-31 |
| NCT03783130 |
Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults |
https://ClinicalTrials.gov/show/NCT03783130 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2020-02-29 |
| NCT03765632 |
Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID |
https://ClinicalTrials.gov/show/NCT03765632 |
Recruiting |
Great Ormond Street Hospital for Children NHS Foundation Trust |
2021-07-31 |
| NCT03746600 |
Technological Intervention for Reducing Alcohol Use Among People Living With HIV/AIDS |
https://ClinicalTrials.gov/show/NCT03746600 |
Recruiting |
University of Georgia |
2022-07-31 |
| NCT03730129 |
Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig |
https://ClinicalTrials.gov/show/NCT03730129 |
Recruiting |
Rochester General Hospital |
2020-11-30 |
| NCT03677557 |
Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment |
https://ClinicalTrials.gov/show/NCT03677557 |
Recruiting |
Ottawa Hospital Research Institute |
2021-08-31 |
| NCT03663933 |
Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation |
https://ClinicalTrials.gov/show/NCT03663933 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2023-05-27 |
| NCT03645460 |
Gene Transfer for ADA-SCID Using an Improved Lentiviral Vector (TYF-ADA) |
https://ClinicalTrials.gov/show/NCT03645460 |
Recruiting |
Shenzhen Geno-Immune Medical Institute |
2020-12-31 |
| NCT03615183 |
A Study of MK-8527 in Human Immunodeficiency Type 1 Virus (HIV-1) Infected Participants (MK-8527-002) |
https://ClinicalTrials.gov/show/NCT03615183 |
Completed |
Merck Sharp & Dohme Corp. |
2019-09-26 |
| NCT03601286 |
Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency |
https://ClinicalTrials.gov/show/NCT03601286 |
Recruiting |
Great Ormond Street Hospital for Children NHS Foundation Trust |
2024-12-31 |
| NCT03597594 |
Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID) |
https://ClinicalTrials.gov/show/NCT03597594 |
Recruiting |
St. Jude Children’s Research Hospital |
2027-07-01 |
| NCT03563742 |
A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection |
https://ClinicalTrials.gov/show/NCT03563742 |
Recruiting |
Johnson & Johnson Pte Ltd |
2021-12-15 |
| NCT03557463 |
Testing a Novel Dairy Protein to Counteract Immunosenescence |
https://ClinicalTrials.gov/show/NCT03557463 |
Completed |
University of California, Davis |
2017-08-01 |
| NCT03538899 |
Autologous Gene Therapy for Artemis-Deficient SCID |
https://ClinicalTrials.gov/show/NCT03538899 |
Recruiting |
University of California, San Francisco |
2038-06-30 |
| NCT03529409 |
Effectiveness & Implementation of a Behavioral Intervention for Adherence and Substance Use in HIV Care in South Africa |
https://ClinicalTrials.gov/show/NCT03529409 |
Active, not recruiting |
University of Maryland, College Park |
2021-01-31 |
| NCT03513328 |
Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation |
https://ClinicalTrials.gov/show/NCT03513328 |
Recruiting |
University of Florida |
2021-06-30 |
| NCT03427593 |
Severe PID With Lymphoproliferation and Neutropenia |
https://ClinicalTrials.gov/show/NCT03427593 |
Completed |
University Hospital, Strasbourg, France |
2018-03-13 |
| NCT01227590 |
Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir) |
https://ClinicalTrials.gov/show/NCT01227590 |
Completed |
University of California, San Francisco |
2011-02-28 |
| NCT01209117 |
A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435 |
https://ClinicalTrials.gov/show/NCT01209117 |
Completed |
ViiV Healthcare |
2011-01-31 |
| NCT01199939 |
A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients |
https://ClinicalTrials.gov/show/NCT01199939 |
Completed |
Tibotec, Inc |
2012-10-31 |
| NCT01199705 |
Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) |
https://ClinicalTrials.gov/show/NCT01199705 |
Completed |
CSL Behring |
2011-08-31 |
| NCT01186575 |
Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision |
https://ClinicalTrials.gov/show/NCT01186575 |
Completed |
University of Washington |
2011-03-31 |
| NCT01175213 |
Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID |
https://ClinicalTrials.gov/show/NCT01175213 |
Completed |
Shire |
2013-08-06 |
| NCT01171495 |
Impact of Nutrition Intervention on HIV/AIDS Infected Patients |
https://ClinicalTrials.gov/show/NCT01171495 |
Completed |
Caribbean Health Research Council |
2009-08-31 |
| NCT01131858 |
Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency |
https://ClinicalTrials.gov/show/NCT01131858 |
Completed |
Karolinska University Hospital |
2011-06-30 |
| NCT01129544 |
Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector |
https://ClinicalTrials.gov/show/NCT01129544 |
Active, not recruiting |
Boston Children’s Hospital |
2022-03-31 |
| NCT01093417 |
Study of Vitamin D and Effect on Heart Disease and Insulin Resistance |
https://ClinicalTrials.gov/show/NCT01093417 |
Completed |
University Hospitals Cleveland Medical Center |
2010-10-31 |
| NCT01090102 |
Mesalamine to Reduce T Cell Activation in HIV Infection |
https://ClinicalTrials.gov/show/NCT01090102 |
Completed |
University of California, San Francisco |
2012-12-31 |
| NCT01086878 |
Safety of Cotrimoxazole in HIV- and HAART-exposed Infants |
https://ClinicalTrials.gov/show/NCT01086878 |
Completed |
Harvard School of Public Health |
2010-10-31 |
| NCT01077960 |
Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome |
https://ClinicalTrials.gov/show/NCT01077960 |
Completed |
EMD Serono |
2006-01-31 |
| NCT01077310 |
Alcohol Pharmacotherapy for HIV+ Prisoners |
https://ClinicalTrials.gov/show/NCT01077310 |
Completed |
Yale University |
2015-08-31 |
| NCT01038076 |
Medications for Chronic HIV: Education and Collaboration |
https://ClinicalTrials.gov/show/NCT01038076 |
Completed |
Boston University |
2013-06-30 |
| NCT01032408 |
Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection |
https://ClinicalTrials.gov/show/NCT01032408 |
Completed |
Chiltern Pesquisa Clinica Ltda |
2011-09-30 |
| NCT01012323 |
A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases |
https://ClinicalTrials.gov/show/NCT01012323 |
Completed |
Octapharma |
2012-06-30 |
| NCT00988039 |
Europe-Africa Research Network for Evaluation of Second-line Therapy |
https://ClinicalTrials.gov/show/NCT00988039 |
Completed |
Medical Research Council |
2014-01-31 |
| NCT00985543 |
Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses. |
https://ClinicalTrials.gov/show/NCT00985543 |
Completed |
Kirby Institute |
2010-01-31 |
| NCT00972699 |
Mentor Mothers: A Sustainable Family Intervention in South African Townships |
https://ClinicalTrials.gov/show/NCT00972699 |
Completed |
University of California, Los Angeles |
2011-12-31 |
| NCT00966160 |
CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes |
https://ClinicalTrials.gov/show/NCT00966160 |
Completed |
University of Cologne |
2008-12-31 |
| NCT00947947 |
Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program |
https://ClinicalTrials.gov/show/NCT00947947 |
Completed |
University of North Carolina, Chapel Hill |
2012-05-31 |
| NCT00923364 |
Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC |
https://ClinicalTrials.gov/show/NCT00923364 |
Completed |
National Institutes of Health Clinical Center (CC) |
2014-06-12 |
| NCT00919854 |
A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected Children |
https://ClinicalTrials.gov/show/NCT00919854 |
Completed |
Tibotec Pharmaceuticals, Ireland |
2010-08-31 |
| NCT00917904 |
An Expanded Safety Study of Dapivirine Gel 4789 in Africa |
https://ClinicalTrials.gov/show/NCT00917904 |
Completed |
International Partnership for Microbicides, Inc. |
2010-09-30 |
| NCT00917891 |
An Expanded Safety Study of Dapivirine Gel 4759 in Africa |
https://ClinicalTrials.gov/show/NCT00917891 |
Completed |
International Partnership for Microbicides, Inc. |
2011-01-31 |
| NCT00908284 |
Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIV |
https://ClinicalTrials.gov/show/NCT00908284 |
Completed |
University of Miami |
2015-11-30 |
| NCT00903682 |
A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients |
https://ClinicalTrials.gov/show/NCT00903682 |
Completed |
Janssen-Cilag International NV |
2010-02-28 |
| NCT00896051 |
TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients |
https://ClinicalTrials.gov/show/NCT00896051 |
Completed |
Janssen R&D Ireland |
2012-04-30 |
| NCT03330795 |
Bilateral Orthotopic Lung Transplant - Bone Marrow Transplant |
https://ClinicalTrials.gov/show/NCT03330795 |
Recruiting |
National Institute of Allergy and Infectious Diseases (NIAID) |
2023-11-30 |
| NCT00838162 |
A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients |
https://ClinicalTrials.gov/show/NCT00838162 |
Completed |
Tibotec Pharmaceuticals, Ireland |
2009-08-31 |
| NCT00814879 |
Pilot Study of a Raltegravir Based NRTI Sparing Regimen |
https://ClinicalTrials.gov/show/NCT00814879 |
Completed |
Yale University |
2013-05-31 |
| NCT00814320 |
Gammagard Liquid and rHuPH20 in PID |
https://ClinicalTrials.gov/show/NCT00814320 |
Completed |
Shire |
2010-11-11 |
| NCT01550341 |
HIV, Buprenorphine, and the Criminal Justice System |
https://ClinicalTrials.gov/show/NCT01550341 |
Completed |
Yale University |
2015-11-30 |
| NCT01385241 |
Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women |
https://ClinicalTrials.gov/show/NCT01385241 |
Completed |
Duke University |
2014-01-31 |
| NCT02823847 |
Non Invasive Oral Cancer Screening Among HIV Infected Individuals |
https://ClinicalTrials.gov/show/NCT02823847 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-07-31 |
| NCT02579967 |
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies |
https://ClinicalTrials.gov/show/NCT02579967 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-12-21 |
| NCT02583464 |
Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg. |
https://ClinicalTrials.gov/show/NCT02583464 |
Completed |
Laboratorio Elea Phoenix S.A. |
2014-10-31 |
| NCT02396979 |
Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia |
https://ClinicalTrials.gov/show/NCT02396979 |
Completed |
Yale University |
2014-12-31 |
| NCT02180763 |
Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps |
https://ClinicalTrials.gov/show/NCT02180763 |
Completed |
Octapharma |
2016-08-28 |
| NCT03961009 |
Efficacy, Safety and Pharmacokinetics Study of Kedrion IVIG 10% to Treat Participants With Primary Immunodeficiency (PID) |
https://ClinicalTrials.gov/show/NCT03961009 |
Recruiting |
Kedrion S.p.A. |
2021-02-16 |
| NCT00794508 |
MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID |
https://ClinicalTrials.gov/show/NCT00794508 |
Completed |
University of California, Los Angeles |
2014-12-31 |
| NCT00782106 |
Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously |
https://ClinicalTrials.gov/show/NCT00782106 |
Completed |
Shire |
2007-11-01 |
| NCT00751621 |
Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study) |
https://ClinicalTrials.gov/show/NCT00751621 |
Completed |
CSL Behring |
2011-12-31 |
| NCT00744692 |
Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders |
https://ClinicalTrials.gov/show/NCT00744692 |
Completed |
Duke University |
2012-12-31 |
| NCT00719680 |
Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID) |
https://ClinicalTrials.gov/show/NCT00719680 |
Completed |
CSL Behring |
2010-06-30 |
| NCT00711009 |
Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL) |
https://ClinicalTrials.gov/show/NCT00711009 |
Completed |
Abbott |
2009-11-30 |
| NCT00698334 |
Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis |
https://ClinicalTrials.gov/show/NCT00698334 |
Completed |
All India Institute of Medical Sciences, New Delhi |
2010-09-30 |
| NCT00692926 |
Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells |
https://ClinicalTrials.gov/show/NCT00692926 |
Completed |
Duke University |
2012-07-31 |
| NCT00680446 |
Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency |
https://ClinicalTrials.gov/show/NCT00680446 |
Completed |
CSL Limited |
2013-05-31 |
| NCT00634569 |
Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects |
https://ClinicalTrials.gov/show/NCT00634569 |
Completed |
Grifols Biologicals, LLC |
2011-03-31 |
| NCT00602758 |
Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIV |
https://ClinicalTrials.gov/show/NCT00602758 |
Completed |
University of Missouri, Kansas City |
2009-08-31 |
| NCT00599781 |
Gene Therapy for ADA-SCID |
https://ClinicalTrials.gov/show/NCT00599781 |
Completed |
IRCCS San Raffaele |
2006-07-31 |
| NCT00598481 |
ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCID |
https://ClinicalTrials.gov/show/NCT00598481 |
Completed |
Orchard Therapeutics |
2011-07-10 |
| NCT00579124 |
CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation for T and B Cell Depletion |
https://ClinicalTrials.gov/show/NCT00579124 |
Active, not recruiting |
Children’s Hospital of Philadelphia |
2021-12-31 |
| NCT00553098 |
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders |
https://ClinicalTrials.gov/show/NCT00553098 |
Completed |
Fred Hutchinson Cancer Research Center |
2015-03-31 |
| NCT00551330 |
Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00551330 |
Completed |
Merck Sharp & Dohme Corp. |
2010-02-28 |
| NCT00546871 |
Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) Subjects |
https://ClinicalTrials.gov/show/NCT00546871 |
Completed |
Shire |
2009-07-01 |
| NCT00542997 |
Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy |
https://ClinicalTrials.gov/show/NCT00542997 |
Completed |
CSL Behring |
2009-08-31 |
| NCT00538915 |
Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD) |
https://ClinicalTrials.gov/show/NCT00538915 |
Completed |
Biotest Pharmaceuticals Corporation |
2009-07-31 |
| NCT00524368 |
A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN) |
https://ClinicalTrials.gov/show/NCT00524368 |
Completed |
Tibotec Pharmaceuticals, Ireland |
2009-08-31 |
| NCT00523211 |
Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5) |
https://ClinicalTrials.gov/show/NCT00523211 |
Completed |
Merck Sharp & Dohme Corp. |
2009-06-30 |
| NCT00520494 |
Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency |
https://ClinicalTrials.gov/show/NCT00520494 |
Completed |
CSL Behring |
2008-10-31 |
| NCT00517803 |
Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies |
https://ClinicalTrials.gov/show/NCT00517803 |
Completed |
Lawson Health Research Institute |
2009-03-02 |
| NCT00502827 |
Smoking Cessation for HIV/AIDS Patients |
https://ClinicalTrials.gov/show/NCT00502827 |
Completed |
M.D. Anderson Cancer Center |
2015-04-30 |
| NCT00478231 |
Multicenter, Safety Study Of Maraviroc |
https://ClinicalTrials.gov/show/NCT00478231 |
Completed |
ViiV Healthcare |
2010-08-31 |
| NCT00474370 |
Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00474370 |
Completed |
Merck Sharp & Dohme Corp. |
2009-08-31 |
| NCT00468273 |
A Clinical Study of Intravenous Immunoglobulin |
https://ClinicalTrials.gov/show/NCT00468273 |
Completed |
FFF Enterprises |
2009-05-31 |
| NCT00458302 |
Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir |
https://ClinicalTrials.gov/show/NCT00458302 |
Completed |
Janssen-Cilag International NV |
2009-02-28 |
| NCT00443378 |
Computer Assisted Rx Education for HIV-Positives: CARE+ |
https://ClinicalTrials.gov/show/NCT00443378 |
Completed |
University of Washington |
2007-06-30 |
| NCT00441688 |
Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients |
https://ClinicalTrials.gov/show/NCT00441688 |
Completed |
ViiV Healthcare |
2007-06-01 |
| NCT00426517 |
Donor Stem Cell Transplantation for Congenital Immunodeficiencies |
https://ClinicalTrials.gov/show/NCT00426517 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-11-01 |
| NCT00419341 |
Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy |
https://ClinicalTrials.gov/show/NCT00419341 |
Completed |
CSL Behring |
2008-10-31 |
| NCT00405184 |
Ig NextGen 10% in Patients With Primary Immune Deficiency (PID) |
https://ClinicalTrials.gov/show/NCT00405184 |
Completed |
CSL Limited |
2008-07-31 |
| NCT00391131 |
Subcutaneous Ig NextGen 16% in PID Patients |
https://ClinicalTrials.gov/show/NCT00391131 |
Completed |
CSL Limited |
2009-10-31 |
| NCT00389324 |
A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency |
https://ClinicalTrials.gov/show/NCT00389324 |
Completed |
Grifols Therapeutics LLC |
2008-08-31 |
| NCT00344591 |
Effectiveness of Structured Ecosystems Therapy for Reducing HIV Risk Behaviors and Improving Treatment Adherence in HIV Infected Men Released From Prison |
https://ClinicalTrials.gov/show/NCT00344591 |
Completed |
University of California, San Francisco |
2009-06-30 |
| NCT00381524 |
HIV Prevention in the Primary Care Setting |
https://ClinicalTrials.gov/show/NCT00381524 |
Completed |
University of Alabama at Birmingham |
2007-06-30 |
| NCT00381212 |
A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent. |
https://ClinicalTrials.gov/show/NCT00381212 |
Completed |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2008-02-29 |
| NCT00358917 |
Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects |
https://ClinicalTrials.gov/show/NCT00358917 |
Completed |
Abbott |
2008-11-30 |
| NCT00358657 |
Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders |
https://ClinicalTrials.gov/show/NCT00358657 |
Active, not recruiting |
Fred Hutchinson Cancer Research Center |
2023-12-01 |
| NCT00337467 |
Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic Suppression |
https://ClinicalTrials.gov/show/NCT00337467 |
Completed |
Bristol-Myers Squibb |
2008-05-31 |
| NCT00335322 |
ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens |
https://ClinicalTrials.gov/show/NCT00335322 |
Completed |
Kirby Institute |
2011-03-31 |
| NCT00325611 |
Multidisciplinary Inpatient Palliative Care Intervention |
https://ClinicalTrials.gov/show/NCT00325611 |
Completed |
Kaiser Permanente |
NA |
| NCT00325585 |
HIV Prevention Intervention for Couples |
https://ClinicalTrials.gov/show/NCT00325585 |
Completed |
National Development and Research Institutes, Inc. |
2007-12-31 |
| NCT00322556 |
Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) |
https://ClinicalTrials.gov/show/NCT00322556 |
Completed |
CSL Behring |
2008-04-30 |
| NCT00296153 |
Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment |
https://ClinicalTrials.gov/show/NCT00296153 |
Completed |
Pronova BioPharma |
2006-11-30 |
| NCT00295971 |
Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease |
https://ClinicalTrials.gov/show/NCT00295971 |
Completed |
University of California, San Francisco |
2011-12-31 |
| NCT00294918 |
An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome |
https://ClinicalTrials.gov/show/NCT00294918 |
Completed |
EMD Serono |
2003-02-28 |
| NCT00294164 |
Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS) |
https://ClinicalTrials.gov/show/NCT00294164 |
Completed |
EMD Serono |
2002-05-31 |
| NCT00278954 |
Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases. |
https://ClinicalTrials.gov/show/NCT00278954 |
Completed |
Bio Products Laboratory |
2007-11-30 |
| NCT00273988 |
Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-dependent Adults |
https://ClinicalTrials.gov/show/NCT00273988 |
Completed |
Boehringer Ingelheim |
2003-10-31 |
| NCT00272220 |
Longitudinal Study of HAART, Social Networks, & Adherence |
https://ClinicalTrials.gov/show/NCT00272220 |
Completed |
University of Washington |
NA |
| NCT00270283 |
A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy |
https://ClinicalTrials.gov/show/NCT00270283 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00270270 |
A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy |
https://ClinicalTrials.gov/show/NCT00270270 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00270010 |
A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease |
https://ClinicalTrials.gov/show/NCT00270010 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00269945 |
A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease |
https://ClinicalTrials.gov/show/NCT00269945 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00263237 |
STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency |
https://ClinicalTrials.gov/show/NCT00263237 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00262522 |
Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects |
https://ClinicalTrials.gov/show/NCT00262522 |
Completed |
Abbott |
2008-07-31 |
| NCT00241202 |
The Efficacy of the HIV/AIDS Symptom Management Manual |
https://ClinicalTrials.gov/show/NCT00241202 |
Completed |
University of California, San Francisco |
2006-12-31 |
| NCT00228852 |
IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency |
https://ClinicalTrials.gov/show/NCT00228852 |
Completed |
Emory University |
NA |
| NCT00220766 |
Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients |
https://ClinicalTrials.gov/show/NCT00220766 |
Completed |
Grifols Therapeutics LLC |
2002-08-31 |
| NCT00176865 |
Stem Cell Transplant for Immunologic or Histiocytic Disorders |
https://ClinicalTrials.gov/show/NCT00176865 |
Completed |
Masonic Cancer Center, University of Minnesota |
2012-08-31 |
| NCT00168025 |
Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) |
https://ClinicalTrials.gov/show/NCT00168025 |
Completed |
CSL Behring |
NA |
| NCT00168012 |
Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID) |
https://ClinicalTrials.gov/show/NCT00168012 |
Completed |
CSL Behring |
NA |
| NCT00161993 |
Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia) |
https://ClinicalTrials.gov/show/NCT00161993 |
Completed |
Shire |
NA |
| NCT00157079 |
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders |
https://ClinicalTrials.gov/show/NCT00157079 |
Completed |
Shire |
2003-12-16 |
| NCT00152100 |
Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome |
https://ClinicalTrials.gov/show/NCT00152100 |
Completed |
St. Jude Children’s Research Hospital |
2007-08-31 |
| NCT00144183 |
A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS) |
https://ClinicalTrials.gov/show/NCT00144183 |
Completed |
Boehringer Ingelheim |
2007-01-31 |
| NCT00144157 |
Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV |
https://ClinicalTrials.gov/show/NCT00144157 |
Completed |
Boehringer Ingelheim |
2006-07-31 |
| NCT00128830 |
A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study |
https://ClinicalTrials.gov/show/NCT00128830 |
Completed |
Tibotec Pharmaceuticals, Ireland |
2008-08-31 |
| NCT00110305 |
A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines |
https://ClinicalTrials.gov/show/NCT00110305 |
Completed |
Tibotec Pharmaceuticals, Ireland |
2011-12-31 |
| NCT00105157 |
Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00105157 |
Completed |
Merck Sharp & Dohme Corp. |
2006-10-31 |
| NCT00100048 |
A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00100048 |
Completed |
Merck Sharp & Dohme Corp. |
2006-10-31 |
| NCT00082628 |
Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients |
https://ClinicalTrials.gov/show/NCT00082628 |
Completed |
EMD Serono |
2005-09-28 |
| NCT00064740 |
Relaxation Response With Acupuncture for HIV Patients |
https://ClinicalTrials.gov/show/NCT00064740 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
NA |
| NCT00055185 |
Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients |
https://ClinicalTrials.gov/show/NCT00055185 |
Completed |
Progenics Pharmaceuticals, Inc. |
NA |
| NCT00000638 |
Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection |
https://ClinicalTrials.gov/show/NCT00000638 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00001968 |
Once-Daily Drug Regimen for HIV-Infected Patients |
https://ClinicalTrials.gov/show/NCT00001968 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001763 |
Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection |
https://ClinicalTrials.gov/show/NCT00001763 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001646 |
Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis |
https://ClinicalTrials.gov/show/NCT00001646 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001538 |
Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers |
https://ClinicalTrials.gov/show/NCT00001538 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001443 |
A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection |
https://ClinicalTrials.gov/show/NCT00001443 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001438 |
A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes |
https://ClinicalTrials.gov/show/NCT00001438 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001267 |
A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2’,3’-Dideoxyinosine |
https://ClinicalTrials.gov/show/NCT00001267 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001542 |
Fluconazole Prophylaxis of Thrush in AIDS |
https://ClinicalTrials.gov/show/NCT00001542 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00033852 |
Treatment of Depression With Massage in HIV |
https://ClinicalTrials.gov/show/NCT00033852 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
NA |
| NCT00033176 |
Immune Restoration by Lipoic Acid in AIDS |
https://ClinicalTrials.gov/show/NCT00033176 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
NA |
| NCT00032721 |
The Use of Reiki for Patients With Advanced AIDS |
https://ClinicalTrials.gov/show/NCT00032721 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
NA |
| NCT00028236 |
Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID) |
https://ClinicalTrials.gov/show/NCT00028236 |
Completed |
National Institutes of Health Clinical Center (CC) |
2011-07-25 |
| NCT00023504 |
Antibody Production in Immune Disorders |
https://ClinicalTrials.gov/show/NCT00023504 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2026-09-19 |
| NCT00002408 |
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients |
https://ClinicalTrials.gov/show/NCT00002408 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002272 |
An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies |
https://ClinicalTrials.gov/show/NCT00002272 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002268 |
A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria |
https://ClinicalTrials.gov/show/NCT00002268 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002255 |
An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC) |
https://ClinicalTrials.gov/show/NCT00002255 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002254 |
A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3’-Deoxy-3’-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC) |
https://ClinicalTrials.gov/show/NCT00002254 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002253 |
A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either “Responders” or “Non-Responders” in a Prior Placebo-Controlled Double-Blind Sandostatin Study. |
https://ClinicalTrials.gov/show/NCT00002253 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002252 |
A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea |
https://ClinicalTrials.gov/show/NCT00002252 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002186 |
Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS) |
https://ClinicalTrials.gov/show/NCT00002186 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002112 |
Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome |
https://ClinicalTrials.gov/show/NCT00002112 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002095 |
A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus |
https://ClinicalTrials.gov/show/NCT00002095 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002090 |
An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS) |
https://ClinicalTrials.gov/show/NCT00002090 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002088 |
Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial |
https://ClinicalTrials.gov/show/NCT00002088 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002082 |
Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study |
https://ClinicalTrials.gov/show/NCT00002082 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002074 |
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome |
https://ClinicalTrials.gov/show/NCT00002074 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002044 |
A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases |
https://ClinicalTrials.gov/show/NCT00002044 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002029 |
Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent |
https://ClinicalTrials.gov/show/NCT00002029 |
Completed |
Abbott |
NA |
| NCT00002028 |
A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2’,3’-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir) |
https://ClinicalTrials.gov/show/NCT00002028 |
Completed |
Bristol-Myers Squibb |
NA |
| NCT00002021 |
An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies |
https://ClinicalTrials.gov/show/NCT00002021 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002019 |
Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome |
https://ClinicalTrials.gov/show/NCT00002019 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002016 |
A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis |
https://ClinicalTrials.gov/show/NCT00002016 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002002 |
A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome |
https://ClinicalTrials.gov/show/NCT00002002 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002001 |
The Antiviral Efficacy of Concurrent Zidovudine and 2’,3’-Dideoxyinosine or 2’,3’-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease |
https://ClinicalTrials.gov/show/NCT00002001 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00001998 |
Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC) |
https://ClinicalTrials.gov/show/NCT00001998 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00001994 |
A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine |
https://ClinicalTrials.gov/show/NCT00001994 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00001386 |
Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection |
https://ClinicalTrials.gov/show/NCT00001386 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00000959 |
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection |
https://ClinicalTrials.gov/show/NCT00000959 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000958 |
A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only) |
https://ClinicalTrials.gov/show/NCT00000958 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000955 |
Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection |
https://ClinicalTrials.gov/show/NCT00000955 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
1992-12-31 |
| NCT00000733 |
Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients |
https://ClinicalTrials.gov/show/NCT00000733 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000726 |
Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome |
https://ClinicalTrials.gov/show/NCT00000726 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000701 |
A Phase I Evaluation of Azidothymidine (AZT) in Children With Acquired Immune Deficiency Syndrome (AIDS) or AIDS Related Complex (ARC) |
https://ClinicalTrials.gov/show/NCT00000701 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000700 |
A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP |
https://ClinicalTrials.gov/show/NCT00000700 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000692 |
Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex |
https://ClinicalTrials.gov/show/NCT00000692 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000684 |
Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals |
https://ClinicalTrials.gov/show/NCT00000684 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000683 |
A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus |
https://ClinicalTrials.gov/show/NCT00000683 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000636 |
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection |
https://ClinicalTrials.gov/show/NCT00000636 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000627 |
Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome |
https://ClinicalTrials.gov/show/NCT00000627 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00018018 |
Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency |
https://ClinicalTrials.gov/show/NCT00018018 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00008450 |
Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant |
https://ClinicalTrials.gov/show/NCT00008450 |
Completed |
Fred Hutchinson Cancer Research Center |
2011-10-25 |
| NCT00006131 |
Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster |
https://ClinicalTrials.gov/show/NCT00006131 |
Completed |
National Center for Research Resources (NCRR) |
NA |
| NCT00004794 |
Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis |
https://ClinicalTrials.gov/show/NCT00004794 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00004695 |
Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency |
https://ClinicalTrials.gov/show/NCT00004695 |
Completed |
FDA Office of Orphan Products Development |
NA |
| NCT00004664 |
Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting |
https://ClinicalTrials.gov/show/NCT00004664 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00001647 |
White Blood Cell Infusions to Treat HIV Infection |
https://ClinicalTrials.gov/show/NCT00001647 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001535 |
Twins Study of Gene Therapy for HIV Infection |
https://ClinicalTrials.gov/show/NCT00001535 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001524 |
Thalidomide to Treat Oral Lesions in HIV-Infected Patients |
https://ClinicalTrials.gov/show/NCT00001524 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001475 |
Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist |
https://ClinicalTrials.gov/show/NCT00001475 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001409 |
Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications |
https://ClinicalTrials.gov/show/NCT00001409 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001354 |
Interleukin-2 Therapy for HIV Infection - Supplemental Procedures |
https://ClinicalTrials.gov/show/NCT00001354 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00000593 |
Viral Activation Transfusion Study (VATS) |
https://ClinicalTrials.gov/show/NCT00000593 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00000590 |
Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185) |
https://ClinicalTrials.gov/show/NCT00000590 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00000587 |
Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection |
https://ClinicalTrials.gov/show/NCT00000587 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00000134 |
Studies of the Ocular Complications of AIDS (SOCA)–Cytomegalovirus Retinitis Retreatment Trial (CRRT) |
https://ClinicalTrials.gov/show/NCT00000134 |
Completed |
Johns Hopkins Bloomberg School of Public Health |
1995-03-31 |
| NCT00000118 |
Ganciclovir Implant Study for Cytomegalovirus Retinitis |
https://ClinicalTrials.gov/show/NCT00000118 |
Completed |
National Eye Institute (NEI) |
NA |